Cryptonews

Unraveling the World of Crypto - One News at a Time

Zymeworks (ZYME) to Acquire Theravance Biopharma (TBPH) for $929M in All-Cash Transaction

Blocknomi

Key Takeaways Zymeworks has entered into an agreement to purchase Theravance Biopharma in an all-cash transaction valued at $929 million at $17 per share Acquisition pricing represents a 3.6% decrease…

Read full article →

Related articles